Norbert Žilka

Norbert Žilka is Chief Science Officer of AXON Neuroscience biotechnological company as well as Director of the Institute of Neuroimmunology of Slovak Academy of Sciences. He is engaged in Alzheimer´s disease research for 22 years. He was involved in development of first vaccine against Alzheimer´s disease and diagnostic test for AD. Norbert Žilka is founder of the first Slovak Brain Bank and author of National programme – Slovakia against dementia. He is publishing in top international scientific journals and organizes also popular science activities.